Cargando…

Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients

BACKGROUND: Coronavirus disease 2019 (COVID-19) raises particular concerns for people with multiple sclerosis (PwMS) on disease-modifying treatments (DMTs), and for physicians caring for them. The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on PwMS receiving DMTs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallucci, Giulia, Zito, Antonio, Baldanti, Fausto, Gastaldi, Matteo, Fabbro, Beatrice Dal, Franciotta, Diego, Bergamaschi, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836789/ https://www.ncbi.nlm.nih.gov/pubmed/33609958 http://dx.doi.org/10.1016/j.msard.2021.102754

Ejemplares similares

Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod
por: Mallucci, Giulia, et al.
Publicado: (2020)

Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment
por: Castellazzi, Massimiliano, et al.
Publicado: (2015)

Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy
por: Castellazzi, Massimiliano, et al.
Publicado: (2016)

Serum MOG-IgG titers should be performed routinely in the diagnosis and follow-up of MOGAD: Commentary
por: Gastaldi, Matteo, et al.
Publicado: (2023)

Air pollution as a contributor to the inflammatory activity of multiple sclerosis
por: Cortese, Andrea, et al.
Publicado: (2020)

Effects of Combined Endurance and Resistance Training in Women With Multiple Sclerosis: A Randomized Controlled Study
por: Correale, Luca, et al.
Publicado: (2021)

COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature
por: Zito, Antonio, et al.
Publicado: (2020)

Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience
por: Cotta Ramusino, Matteo, et al.
Publicado: (2021)

PM(2.5) exposure as a risk factor for multiple sclerosis. An ecological study with a Bayesian mapping approach
por: Bergamaschi, Roberto, et al.
Publicado: (2020)

The economic impact of comorbidity in multiple sclerosis
por: Ponzio, Michela, et al.
Publicado: (2022)

Circulating endothelial progenitor cells during pregnancy in multiple sclerosis
por: Mallucci, Giulia, et al.
Publicado: (2020)

Connections Between Febrile Infection-Related Epilepsy Syndrome and Autoimmune Encephalitis. A Case Report of a Child With New Anti-neuronal Antibodies
por: Basso, Martina, et al.
Publicado: (2022)

Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis
por: Greco, Giacomo, et al.
Publicado: (2023)

Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis
por: Spagni, Gregorio, et al.
Publicado: (2022)

Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
por: Ferraro, Diana, et al.
Publicado: (2020)

A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients
por: Cassotta, Antonino, et al.
Publicado: (2019)

Barriers to exercise and the role of general practitioner: A cross-sectional survey among people with multiple sclerosis
por: Correale, Luca, et al.
Publicado: (2022)

Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy: Two Case Reports and a Systematic Literature Review
por: Greco, Giacomo, et al.
Publicado: (2023)

Autoantibody Diagnostics in Neuroimmunology: Experience From the 2018 Italian Neuroimmunology Association External Quality Assessment Program
por: Gastaldi, Matteo, et al.
Publicado: (2020)

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
por: Jarius, Sven, et al.
Publicado: (2010)

Guillain–Barré Syndrome Associated with SARS-CoV-2
por: Toscano, Gianpaolo, et al.
Publicado: (2020)

Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica
por: Paul, Friedemann, et al.
Publicado: (2007)

The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis
por: De Silvestri, A., et al.
Publicado: (2019)

Description and preliminary experience with Virtual Visit Assessment (ViVA) during the COVID-19 pandemic, a structured virtual management protocol for patients with multiple sclerosis
por: Bergamaschi, Roberto, et al.
Publicado: (2021)

Antibody therapy for COVID-19
por: Hammarström, Lennart, et al.
Publicado: (2021)

SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020)

CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
por: Schiavetti, Irene, et al.
Publicado: (2023)

Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
por: Jalkh, Georges, et al.
Publicado: (2020)

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies
por: Gastaldi, Matteo, et al.
Publicado: (2015)

Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital
por: Sammartino, Josè Camilla, et al.
Publicado: (2022)

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
por: Serafini, Barbara, et al.
Publicado: (2007)

Cellular DNA quantification in respiratory samples for the normalization of viral load: a real need?
por: Piralla, Antonio, et al.
Publicado: (2018)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes
por: Fornara, Chiara, et al.
Publicado: (2023)

Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2019)

Functional outcome in patients with traumatic or hemorrhagic brain injuries undergoing decompressive craniectomy versus craniotomy and 6-month rehabilitation
por: Pingue, Valeria, et al.
Publicado: (2023)

Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children
por: Ricciardi, Alessandra, et al.
Publicado: (2022)

Early red nucleus atrophy in relapse‐onset multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2020)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
por: Piralla, Antonio, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1rtt3vhjgcnatvme8c8136efn1